Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma.
Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma.
复制标题
晚期糖基化终末产物基因受体中的Rs1800625易导致重大创伤患者败血症和多器官功能障碍综合征
DOI:
10.1186/s13054-014-0727-2
复制
发表时间:
2015-01-09
期刊:
影响因子:
--
通讯作者:
Jiang JX
中科院分区:
文献类型:
--
作者:
Zeng L;Du J;Gu W;Zhang AQ;Wang HY;Wen DL;Qiu L;Yang XT;Sun JH;Zhang M;Hao J;Jiang JX
The receptor for advanced glycation end products (RAGE) is a transmembrane receptor of the immunoglobulin superfamily, it plays pivotal roles in the pathogenesis of sepsis in several ways. Our previous study showed that rs1800625 (−429T/C) revealed a strong clinical relevance with sepsis morbidity rate and multiple organ dysfunction syndrome (MODS) in patients with major trauma. In this study, we enlarged the sample size, added two validation populations and examined the expression of RAGE on the surface of peripheral leukocytes to ex vivo lipopolysaccharide (LPS) stimulation in subjects with different genotypes. Rs1800625 was genotyped using pyrosequencing in 837 Chinese Han patients with major trauma in Chongqing. We then validated the clinical relevance in 340 Zhejiang and 347 Yunnan patients. The expression of RAGE on the surface of peripheral blood mononuclear cells was measured by flow cytometric analysis. The results indicated that rs1800625 was significantly associated with sepsis morbidity rate and MODS in patients with major trauma in the Chongqing, Zhejiang and Yunnan districts. Patients with CC genotype had lower sepsis morbidity rate and MODS after major trauma. Furthermore, patients with CC genotype had significantly higher RAGE expression (P = 0.009). The rs1800625 polymorphism is a functional single nucleotide polymorphism and confers host susceptibility to sepsis and MODS in patients with major trauma.
登录
查看更多内容
影响因子:
2
作者:
Wang, Zhengguo;Jiang, Jianxin
通讯作者:
Jiang, Jianxin
DOI:
10.1073/pnas.94.10.5296
发表时间:
1997-05-13
影响因子:
11.1
作者:
Yan, SD;Zhu, HJ;Schmidt, AM
通讯作者:
Schmidt, AM
影响因子:
2.9
作者:
Xue J;Ray R;Singer D;Böhme D;Burz DS;Rai V;Hoffmann R;Shekhtman A
通讯作者:
Shekhtman A
DOI:
10.1016/s0197-2456(98)00037-3
发表时间:
1998-12-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
Dupont, WD;Plummer, WD
通讯作者:
Plummer, WD
影响因子:
8.8
作者:
Levy, MM;Fink, MP;Ramsay, G
通讯作者:
Ramsay, G